Supplementary Figure S11 from Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs

Shreoshi Pal Choudhuri; Luc Girard; Jun Yi Stanley Lim; Jillian F. Wise; Braeden Freitas; Di Yang; Edmond Wong; Seth Hamilton; Victor D. Chien; Yoon Jung Kim; Collin Gilbreath; Jun Zhong; Sarah Phat; David T. Myers; Camilla L. Christensen; Hanieh Mazloom-Farsibaf; Marcello Stanzione; Kwok‐Kin Wong; Yin P. Hung; Anna F. Farago; Catherine B. Meador; Nicholas J. Dyson; Michael S. Lawrence; Sihan Wu; Benjamin J. Drapkin

doi:10.1158/2159-8290.25729192.v1

Abstract

Frequency of amplified oncogenes across PDX panel, similarity of ecMYC/L/N structures, and regression analysis of average drug response versus MYC paralog copy number, expression and amplicon type.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Choudhuri et al. (2024) studied this question.

synapsesocial.com/papers/68e6c4b3b6db6435876434e8 https://doi.org/10.1158/2159-8290.25729192.v1

View Full Paper

Ask AI

Bookmark

Abstract

Frequency of amplified oncogenes across PDX panel, similarity of ecMYC/L/N structures, and regression analysis of average drug response versus MYC paralog copy number, expression and amplicon type.

Supplementary Figure S11 from Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs

Abstract

Discussion

Cite This Study

Supplementary Figure S11 from Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers